Alec Stranahan
Stock Analyst at Bank of America Securities
(0.73)
# 4,136
Out of 5,060 analysts
645
Total ratings
43.5%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Reiterated: Hold | $6 | $3.47 | +73.16% | 26 | Oct 16, 2026 | |
| ALEC Alector | Reiterated: Sell | $1 | $1.84 | -45.65% | 18 | Oct 14, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | $82 → $81 | $49.25 | +64.47% | 28 | Oct 9, 2026 | |
| MRNA Moderna | Reiterated: Hold | n/a | $218.01 | - | 28 | Oct 9, 2026 | |
| NVAX Novavax | Reiterated: Sell | $7 → $8 | $11.26 | -28.95% | 44 | Oct 9, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $265 → $264 | $177.96 | +48.35% | 39 | Oct 9, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | $50 | $31.32 | +59.64% | 36 | Oct 6, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $17 | $3.13 | +443.13% | 8 | Oct 1, 2026 | |
| CADL Candel Therapeutics | Reiterated: Buy | $18 | $8.19 | +119.78% | 20 | Sep 30, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $8 | $1.31 | +510.69% | 3 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $14.16 | +27.16% | 24 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $392 → $400 | $316.58 | +26.35% | 33 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.93 | +116.61% | 30 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $26 | $22.85 | +13.79% | 20 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $23.47 | +83.21% | 25 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $13.39 | +49.37% | 28 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $6.73 | +152.60% | 18 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $15.06 | +125.76% | 9 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $2.17 | +130.41% | 18 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $0.4699 | +964.06% | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $9.28 | +104.74% | 17 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $2.27 | +164.32% | 13 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $11.27 | +210.56% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $88 | $59.87 | +47.00% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.35 | - | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $22 | $16.51 | +33.25% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $11.42 | +48.86% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $9.96 | +50.60% | 21 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 → $21 | $53.97 | -61.09% | 38 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $0.0289 | +3,360.21% | 1 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $800 → $565 | $790.74 | n/a | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,150 → $1,100 | $1,257.03 | n/a | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $18.44 | n/a | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $1 | $6.34 | n/a | 4 | Dec 2, 2022 |
Recursion Pharmaceuticals
Oct 16, 2026
Reiterated: Hold
Price Target: $6
Current: $3.47
Upside: +73.16%
Alector
Oct 14, 2026
Reiterated: Sell
Price Target: $1
Current: $1.84
Upside: -45.65%
CRISPR Therapeutics AG
Oct 9, 2026
Reiterated: Buy
Price Target: $82 → $81
Current: $49.25
Upside: +64.47%
Moderna
Oct 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $218.01
Upside: -
Novavax
Oct 9, 2026
Reiterated: Sell
Price Target: $7 → $8
Current: $11.26
Upside: -28.95%
Revolution Medicines
Oct 9, 2026
Reiterated: Buy
Price Target: $265 → $264
Current: $177.96
Upside: +48.35%
Agios Pharmaceuticals
Oct 6, 2026
Reiterated: Buy
Price Target: $50
Current: $31.32
Upside: +59.64%
Wave Life Sciences
Oct 1, 2026
Reiterated: Buy
Price Target: $17
Current: $3.13
Upside: +443.13%
Candel Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $18
Current: $8.19
Upside: +119.78%
ProQR Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $8
Current: $1.31
Upside: +510.69%
Sep 21, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $14.16
Upside: +27.16%
Sep 21, 2026
Reiterated: Buy
Price Target: $392 → $400
Current: $316.58
Upside: +26.35%
Sep 21, 2026
Reiterated: Buy
Price Target: $15
Current: $6.93
Upside: +116.61%
Sep 21, 2026
Reiterated: Hold
Price Target: $20 → $26
Current: $22.85
Upside: +13.79%
Sep 8, 2026
Reiterated: Buy
Price Target: $43
Current: $23.47
Upside: +83.21%
Aug 26, 2026
Reiterated: Hold
Price Target: $20
Current: $13.39
Upside: +49.37%
Aug 18, 2026
Reiterated: Buy
Price Target: $17
Current: $6.73
Upside: +152.60%
Aug 14, 2026
Reiterated: Buy
Price Target: $34
Current: $15.06
Upside: +125.76%
Aug 14, 2026
Reiterated: Hold
Price Target: $6 → $5
Current: $2.17
Upside: +130.41%
Aug 14, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $0.4699
Upside: +964.06%
Aug 14, 2026
Reiterated: Buy
Price Target: $19
Current: $9.28
Upside: +104.74%
Aug 14, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $2.27
Upside: +164.32%
Aug 7, 2026
Reiterated: Buy
Price Target: $35
Current: $11.27
Upside: +210.56%
Aug 7, 2026
Reiterated: Buy
Price Target: $87 → $88
Current: $59.87
Upside: +47.00%
Aug 7, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.35
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $21 → $22
Current: $16.51
Upside: +33.25%
Aug 7, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $11.42
Upside: +48.86%
Aug 7, 2026
Reiterated: Buy
Price Target: $16 → $15
Current: $9.96
Upside: +50.60%
Aug 5, 2026
Reiterated: Sell
Price Target: $20 → $21
Current: $53.97
Upside: -61.09%
Mar 27, 2026
Reiterated: Sell
Price Target: $1
Current: $0.0289
Upside: +3,360.21%
Dec 10, 2024
Initiated Coverage: Sell
Price Target: $800 → $565
Current: $790.74
Upside: n/a
Nov 1, 2024
Rated: Buy
Price Target: $1,150 → $1,100
Current: $1,257.03
Upside: n/a
Aug 15, 2023
Reiterated: Buy
Price Target: $6 → $5
Current: $18.44
Upside: n/a
Dec 2, 2022
Reiterated: Sell
Price Target: $10 → $1
Current: $6.34
Upside: n/a